Reduced expression of the retinoblastoma protein shows that the related signaling pathway is essential for mediating the antineoplastic activity of erufosine.
Erufosine is a new antineoplastic agent of the group of alkylphosphocholines, which interferes with signal transduction and induces apoptosis in various leukemic and tumor cell lines. The present study was designed to examine for the first time the mechanism of resistance to erufosine in malignant c...
Guardado en:
Autores principales: | Maya M Zaharieva, Milen Kirilov, Minquang Chai, Stefan M Berger, Spiro Konstantinov, Martin R Berger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b1d12f7a84f64cbf9ebb18b8f19d9578 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Gustavo Henrique Rodrigues da Silva, et al.
Publicado: (2021) -
Retinoblastoma
por: Marchevsky,Silvia, et al.
Publicado: (1979) -
Tumor targeting using liposomal antineoplastic drugs
por: Jörg Huwyler, et al.
Publicado: (2008) -
Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway
por: Shu Wen, et al.
Publicado: (2021) -
The Interference of COVID-19 in the Oral Cancer Diagnosis and Antineoplastic Treatment
por: Correia-Neto,Ivan José, et al.
Publicado: (2021)